Navigation Links
Carnegie donates landmark clones to biology
Date:8/6/2009

Palo Alto, CAWith the information explosion, it's remarkable that so little is known about the interactions that proteins have with each other and the protective membrane that surrounds a cell. These interactive, so-called membrane proteins regulate nutrients and water fluxes, sense environmental threats, and are the communications interface with neighboring cells and within the cell. Now with National Science Foundation funding, researchers at the Carnegie Institution's Department of Plant Biology have cloned genes to produce membrane proteins that may initiate the instructions for genes to turn on in the nucleus. They just donated 2010 of the clones for genes that function in the cell's interaction with its environment to the Arabidopsis Biological Resource Center (ABRC is at Ohio State University) for other scientists to use to help advance fields from medicine to farming. These genes are now used to unravel the interaction of the membrane proteins amongst each other.

Recent research at the Carnegie department has shown that cells across different species use the same mechanism at the cell membrane to regulate the uptake of the vital nutrient nitrogen. Previous Carnegie work indicated that plants have a novel regulatory mechanism that controls nutrient uptakeneighboring pore-like structures at a plant cell's surface physically interact to control the uptake. "Since plants, animals, bacteria, and fungi all share similar genes for this activity, we wanted to see in this study if same feature could occur across species," remarked Dominique Loqu lead author of a study published in the July 6, Journal of Biological Chemistry.

In the previous work, the scientists looked at the end of the protein Arabidopsis ammonium transporter (AMT1;1). This protein portion is called the C-terminus and it regulates the interactions of the pore-like structures at the membrane surface in plants. In this study they focused on the underlying mechanism of the pore activity by using mutant proteins that cannot shut the pores off with their C-terminus to see how they work in yeast and immature eggs of the frog Xenopus in the presence of ammonium.

The researchers were totally surprised that the mechanism in which three subunits regulate each other was found in the primitive archaebacteria. It means that it evolved billions of years ago. The fact that the C-terminus is found in all other bacteria, fungi, and plants demonstrates that it was necessary in the atmosphere where they developedperiods in which the toxic ammonium accumulated on the early Earth. This mechanism has been retained although a single mutation can make the transporters work independently. So why did this simpler mutation not succeed? The researchers believe that there must still be selective pressure on the system. The simplest explanation is that the mechanism is still necessary today, probably to control uptake and prevent toxicity.

"The newly donated 2010 clones will now be used to see how common such regulation by neighbors is. It also emphasizes the importance and the potential that the new clones have for understanding a spectrum of problems from kidney diseases to engineering better crops," remarked director of the department Wolf Frommer.


'/>"/>

Contact: Wolf Frommer
wfrommer@ciw.edu
650-325-1521
Carnegie Institution
Source:Eurekalert

Related biology news :

1. Carnegie Mellon scientists develop nanogels that enable controlled delivery of carbohydrate drugs
2. Carnegie Mellon scientists investigate initial molecular mechanism that triggers neuronal firing
3. Carnegie Mellon scientist uses mass spectrometer to weigh virus particle, von Willebrand factor
4. Carnegie Mellon, Pitt Team to study psychosocial stress
5. Mellon awards Carnegie Grant for Ecological Monitoring in South Africa
6. Carnegie Mellon researchers to develop new drug delivery system
7. Carnegie Mellon students win contest
8. Novel mechanism for long-term learning identified by Carnegie Mellon researchers
9. U. Mass Medical School and Carnegie announce licensing agreements with Oxford BioMedica
10. Carnegie Mellon scientists develop fluorescent proteins for live cell imaging, biosensor design
11. Carnegie Mellon receives $1.85 million
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/28/2017)... News solutions for biometrics, bag drop and New ADA-compliant ... At PTE ... March, Materna will present its complete end-to-end passenger journey, ... real benefit for passengers. To accelerate the whole passenger handling ... solutions to take passengers through the complete integrated process with ...
(Date:2/22/2017)... 22, 2017 With the biometrics market ... identifies four technologies that innovative and agile startups ... share in the changing competitive landscape: multifactor authentication ...   "Companies can no longer afford ... says Dimitrios Pavlakis , Industry Analyst at ...
(Date:2/13/2017)... , Feb. 13, 2017  RSA Conference -- ... platform that is designed to enhance fraud detection ... release in the RSA Fraud & Risk Intelligence ... organizations to leverage additional insights from internal and ... to better protect their customers from targeted cybercrime ...
Breaking Biology News(10 mins):
(Date:3/24/2017)... 2017 MiMedx Group, Inc. (NASDAQ: MDXG), the ... tissue allografts and patent-protected processes to develop and market ... announced today  that it will present at the Needham ... NY.  Parker H. "Pete" Petit, Chairman and CEO, ... M. Cashman , EVP and Chief Commercialization Officer, and ...
(Date:3/24/2017)... , March 24, 2017   Sienna Biopharmaceuticals, Inc. ... company, today announced that Richard Peterson will ... 24.   Peterson, who brings more than two ... Smither , who is retiring at the end of ... advisory capacity. Peterson joins Sienna from Novan, Inc., where ...
(Date:3/23/2017)... 2017  Northwest Biotherapeutics (OTCQB: NWBO) (NW Bio), ... for solid tumor cancers, today announced that yesterday ... announced last Friday, March 17, 2017. ... securities totaling 28,843,692 shares, comprised of 18,843,692 common ... of Class C Warrants pre-funded at the closing ...
(Date:3/23/2017)... 2017 Kineta, Inc., a biotechnology company ... in immuno-oncology, today announced the discovery and characterization ... that activate interferon response factor 3 (IRF3) via ... tumor regression in a murine colon carcinoma mouse ... complete tumor regression to initial drug treatment were ...
Breaking Biology Technology: